Role of the ovary in the adrenal androgen excess of hyperandrogenic women

Fertility and Sterility

Volumn 69, Issue 5, 1998, Pages 851-859

  Azziz, Ricardo ^a   Rittmaster, Roger S ^b   Fox, Leisl M ^b   Bradley Jr , Edwin L ^b   Potter, H Downing ^b   Boots, Larry R ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

Adrenal; Androgens; Gonadotropin releasing hormone analogues; Hirsutism; Polycystic ovary syndrome

Indexed keywords

11BETA HYDROXYANDROSTENEDIONE; ANDROGEN; ANDROSTENEDIOL; ANDROSTENEDIONE; CONJUGATED ESTROGEN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HYDROCORTISONE; LEUPRORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TETRACOSACTIDE;

ADRENAL CORTEX; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HIRSUTISM; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MULTICENTER STUDY; OLIGOMENORRHEA; ORAL DRUG ADMINISTRATION; OVARY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEROIDOGENESIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032080183     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00033-8     Document Type: Article

References (29)

1. 1. Hoffman DI, Klove K, Lobo RA. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 1984;42:76-81.
2. 2. Wild RA, Umstot ED, Andersen RN, Ranney GB, Givens JR. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983;146:602-5.
3. 3. Carmina E, Rosato F, Janni A. Increased DHEAS levels in PCO syndrome: evidence for the existence of two subgroups of patients. J Endocrinol Invest 1986;9:5-9.
4. 4. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-12.
5. 5. Stanzcyk FZ, Chang L, Carmina E, Putz Z, Lobo RA. Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol 1991;165:1837-42.
6. 6. Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu JKH, Vale WW, et al. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1983;56:897-903.
7. 7. Rittmaster RS, Thompson DL. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 1990;70:1096-1990.
8. 8. Cedars MI, Steingold KA, de Ziegler D, Lapolt PS, Chang RJ, Judd HL. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Fertil Steril 1992;57:495-500.
9. 9. Gonzalez F, Hatala DA, Speroff L. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am J Obstet Gynecol 1991;165:535-45.
10. 10. Carmina E, Gonzalez F, Chang L, Lobo RA. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome. Obstet Gynecol 1995;85:971-6.
11. 11. Escobar-Morreale H, Pazos F, Potau N, Garcia-Robles R, Sancho JM, Varela C. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperandrogenism: role of adrenal and ovarian cytochrome P450c17α. Fertil Steril 1994;64:521-30.
12. 12. Fruzzetti F, De Lorenzo D, Ricci C, Teti G. Ovarian influence on adrenal secretion in polycystic ovary syndrome. Fertil Steril 1995;63: 734-41.
13. 13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-30.
14. 14. Azziz R, Zacur HA. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 1989;69: 577-84.
15. 15. Azziz R. Hirsutism. In: Sciarra JJ, Dilts PV, editors. Gynecology and obstetrics. Vol. 5. Philadelphia: J.B. Lippincott Co., 1994:1-22.
16. 16. Azziz R, Ochoa TM, Bradley EL Jr, Potter HD, Boots LR. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab 1995; 80:3406-11.
17. 17. Azziz R, Bradley EL Jr, Potter HD, Parker CR Jr, Boots LR. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. Am J Obstet Gynecol 1995;172:1251-6.
18. 18. Pearlman WH, Crepy O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J Biol Chem 1967; 242:182-9.
19. 5-Androstene-3β,17β-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile. Fertil Steril 1994;62:321-6.
20. 20. Murphy BEP. Methodological problems in competitive protein-binding techniques: the use of Sephadex column chromatography to separate steroids. In: Diczfalusy E, Diczfalusy A, editors. Proceedings of the Karolinska Symposia on Research Methods in Reproductive Endocrinology, 2nd Symposium: Steroid Assay by Protein Binding. Stockholm, Sweden: Karolinska Institute, 1970:37-60.
21. 21. Ditkoff EC, Fruzzetti F, Chang L, Stancyzk FZ, Lobo RA. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:603-7.
22. 22. Castelo-Branco C, Martinez de Osaba MJ, Martinez S, Fortuny A. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism. Metabolism 1996;45:24-7.
23. 23. Gonzalez F, Chang L, Horab T, Lobo RA. Evidence for heterogenous etiologies of adrenal dysfunction in polycystic ovary syndrome. Fertil Steril 1996;66:354-61.
24. 24. O'Hare MJ, Nice EC, Neville AM. Regulation of androgen secretion and sulfoconjugation in the adult human adrenal cortex: studies with primary monolayer cell cultures. In: Genazzani AR, Thijssen JHH, Siiteri PK, editors. Adrenal androgens. New York: Raven Press, 1980: 7-25.
25. 25. Azziz R, Gay F, Potter SR, Bradley E Jr, Boots LR. Effect of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. J Clin Endocrinol Metab 1991;72:1025-30.
26. 26. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1980;51:330-3.
27. 27. Rittmaster RS. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide. J Clin Endocrinol Metab 1988;67:651-5.
28. 28. Rittmaster RS, Arab DM, Lehman L. Dose-response effect of depot leuprolide on serum androgens in women. Fertil Steril 1996;65:912-5.
29. 29. Rittmaster RS. Androgen conjugates: physiology and clinical significance. Endocr Rev 1993;14:121-32.